Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03649074 · ClinicalTrials.gov registry record · NA

Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by Akili Interactive Labs.

Completed
Registry status
NA
Development phase
206
Enrollment target
2
Study locations

NCT03649074 is a NA study of Attention Deficit Hyperactivity Disorder that has completed, run by Akili Interactive Labs. The registered enrollment target is 206 participants, roughly in line with the 204-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03649074, a NA study of Attention Deficit Hyperactivity Disorder, has completed, sponsored by Akili Interactive Labs.

COMPLETED
Registry status
NA
Development phase
206 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to determine the effects of combining AKL-T01 (with AKL-X01 symptom tracking) as adjunctive treatment to stimulant medication, and to understand the effects of AKL-T01 treatment (with AKL-X01 symptom tracking) in participants not recently on medication.

Conditions Studied

Attention Deficit Hyperactivity Disorder

Interventions

  • DEVICE AKL-T01

Study Locations (2)

Arizona

  • Melmed Center - Scottsdale

Nevada

  • Center for Psychiatry and Behavioral Medicine - Las Vegas

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2018-12-28
Est. Completion 2019-09-23
Phase NA

Sponsor

Akili Interactive Labs

13 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03649074

The ClinicalTrials.gov registry entry for NCT03649074 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 204-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target. The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which AKL-T01 is the first listed.

NCT03649074 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Nevada.

Frequently Asked Questions

What is clinical trial NCT03649074 about?

NCT03649074 is a clinical study titled "Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant". The purpose of this study is to determine the effects of combining AKL-T01 (with AKL-X01 symptom tracking) as adjunctive treatment to stimulant medication, and to understand the effects of AKL-T01 treatment (with AKL-X01 symptom tracking) in participants not recently on medication.

What is the current status of trial NCT03649074?

This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2018-12-28. Estimated completion is 2019-09-23.

What conditions does trial NCT03649074 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT03649074?

The interventions under investigation include: AKL-T01 (DEVICE).

Who is sponsoring clinical trial NCT03649074?

This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03649074 being conducted?

This trial has 2 study locations across Arizona, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Hyperactivity Disorder

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.